MedTrace Logo

Assessing Open Access Audio

NCT04452331 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1553

Last updated 2025-04-03

Study results available
· View outcomes & findings →

Summary

The medical encounter can be overwhelming in term of the amount of information discussed, its technical nature, and the anxiety it can generate. Easy access to a secure audio recording from any internet enabled device is an available low cost technology that allows patients to "revisit the visit" either alone or sharing with caretakers and family. It has been introduced and tested outside the VA with evidence that it increases patient recall and understanding and may even improve physician performance. Little is known, however, about whether and to what extent these effects lead to better outcomes, such as improved treatment plan adherence and chronic disease self-management. This study is a randomized controlled trial designed ascertain whether easy access to audio recordings of the medical visit improves patients perception that they understand and can manage their own care, and leads to a variety of improved outcomes, such as better blood pressure and diabetes control, and fewer emergency department visits and hospitalizations.

Conditions

Interventions

OTHER

Open Access Audio

Patient obtains secure access to an audio recording of the medical encounter post-visit that is accessible from any internet enabled device.

OTHER

No Access, Patient and Provider Aware of Recording

Patient does not obtain access to audio recording but both patient and provider are aware visit is being recorded.

OTHER

No Access, Provider Unaware of Recording

Patient does not obtain access to audio recording and provider is unaware visit is being recorded.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Saul J. Weiner, MD · Jesse Brown VA Medical Center, Chicago, IL

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-05
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04452331 on ClinicalTrials.gov